{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:55:47Z","timestamp":1760100947949,"version":"3.41.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2003,3,6]],"date-time":"2003-03-06T00:00:00Z","timestamp":1046908800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2003,4]]},"DOI":"10.1007\/s00228-003-0559-5","type":"journal-article","created":{"date-parts":[[2016,11,12]],"date-time":"2016-11-12T18:50:14Z","timestamp":1478976614000},"page":"813-820","source":"Crossref","is-referenced-by-count":29,"title":["Limited sampling strategies using Bayesian estimation or multilinear regression for cyclosporin AUC0\u201312 monitoring in cardiac transplant recipients over the first year post-transplantation"],"prefix":"10.1007","volume":"58","author":[{"given":"C.","family":"Monchaud","sequence":"first","affiliation":[]},{"given":"A.","family":"Rousseau","sequence":"additional","affiliation":[]},{"given":"F.","family":"Leger","sequence":"additional","affiliation":[]},{"given":"O. J.","family":"David","sequence":"additional","affiliation":[]},{"given":"J.","family":"Debord","sequence":"additional","affiliation":[]},{"given":"T.","family":"Dantoine","sequence":"additional","affiliation":[]},{"given":"P.","family":"Marquet","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2003,3,6]]},"reference":[{"key":"0559_CR1","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/00007691-199512000-00017","volume":"17","author":"Oellerich","year":"1995","unstructured":"Oellerich M, Armstrong VW, Kahan B, Shaw L, Holt DW, Yatscoff R, Lindholm A, Halloran P, Gallicano K, Wonigeit K et al (1995) Lake Louise consensus document: Hawk's Cay meeting in organ transplantation: report of the consensus panel. Ther Drug Monit 17:642\u2013654","journal-title":"Ther Drug Monit"},{"key":"0559_CR2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/00003088-200039020-00003","volume":"39","author":"Belitsky","year":"2000","unstructured":"Belitsky P, Dunn S, Jonhston A, Levy G (2000) Impact of absorption profiling on efficacy and safety of cyclosporin therapy in transplant recipients. Clin Pharmacokinet 39:117\u2013125","journal-title":"Clin Pharmacokinet"},{"key":"0559_CR3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/clpt.1993.132","volume":"54","author":"Lindholm","year":"1993","unstructured":"Lindholm A, Kahan BD (1993) Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation. Clin Pharmacol Ther 54:205\u2013218","journal-title":"Clin Pharmacol Ther"},{"key":"0559_CR4","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/S0041-1345(98)00375-3","volume":"30","author":"Keown","year":"1998","unstructured":"Keown P, Kahan BD, Johnston A, Levy G, Dunn SP, Cittero F, Grino JM, Hoyer PF, Wolf P, Halloran PF (1998) Optimization of cyclosporine therapy with new therapeutic drug monitoring strategies: report from the international Neoral TDM advisory consensus meeting (Vancouver, November 1997). Transplant Proc 30:1645\u20131649","journal-title":"Transplant Proc"},{"key":"0559_CR5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2165\/00003088-200038050-00004","volume":"38","author":"Dumont","year":"2000","unstructured":"Dumont JR, Ensom MH (2000) Methods for clinical monitoring of cyclosporine in transplant patients. Clin Pharmacokinet 38:427\u2013447","journal-title":"Clin Pharmacokinet"},{"key":"0559_CR6","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1097\/00007890-199912270-00003","volume":"12","author":"Cantarovich","year":"1999","unstructured":"Cantarovich M, Elstein E, de Varennes B, Barkun JS (1999) Clinical benefit of Neoral dose monitoring with cyclosporine 2-hr post-dose levels compared with trough levels in stable heart transplant patients. Transplantation 12:1839\u20131842","journal-title":"Transplantation"},{"key":"0559_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0009-9120(00)00175-2","volume":"34","author":"Armstrong","year":"2001","unstructured":"Armstrong VW, Oellerich M (2001) New developments in the immunosuppressive drug monitoring of cyclosporine, tacrolimus, and azathioprine. Clin Biochem 34:9\u201316","journal-title":"Clin Biochem"},{"key":"0559_CR8","doi-asserted-by":"crossref","first-page":"45S","DOI":"10.1016\/S0041-1345(00)00863-0","volume":"32","author":"Belitsky","year":"2000","unstructured":"Belitsky P, Levy GA, Johnston A (2000) Neoral absorption profiling: an evolution in effectiveness. Transplant Proc 32:45S","journal-title":"Transplant Proc"},{"key":"0559_CR9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2165\/00063030-200115050-00001","volume":"15","author":"Levy","year":"2001","unstructured":"Levy G (2001) C2 monitoring strategy for optimising cyclosporin immunosuppression from Neoral formulation. Biodrugs 15:279\u2013290","journal-title":"Biodrugs"},{"key":"0559_CR10","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/S0041-1345(00)02598-7","volume":"33","author":"Cooney","year":"2001","unstructured":"Cooney GF, Johnston A (2001) Neoral C-2 monitoring in cardiac transplant patients. Transplant Proc 33:1572\u20131575","journal-title":"Transplant Proc"},{"key":"0559_CR11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1399-0012.1998.tb01098.x","volume":"12","author":"Cantarovich","year":"1998","unstructured":"Cantarovich M, Besner JG, Barkun JS, Elstein E, Loertscher R (1998) Two-hour cyclosporine level determination is the appropriate tool to monitor Neoral therapy. Clin Transplant 12:243\u2013249","journal-title":"Clin Transplant"},{"key":"0559_CR12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/00007691-200104000-00003","volume":"23","author":"David","year":"2001","unstructured":"David O, Johnston A (2001) Limited sampling strategies for estimating cyclosporin area under the concentration\u2013time curve: review of current algorithms. Ther Drug Monit 23:100\u2013114","journal-title":"Ther Drug Monit"},{"key":"0559_CR13","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1016\/S0041-1345(98)01123-3","volume":"30","author":"Lee","year":"1998","unstructured":"Lee KL, Lee KT, Chung HM, Lin YP (1998) Estimation of mean relative bioavailability of cyclosporine Sandimmune and Neoral using NONMEM, in renal transplant recipients. Transplant Proc 30:3526\u20133529","journal-title":"Transplant Proc"},{"key":"0559_CR14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/00003088-200241010-00006","volume":"41","author":"Leger","year":"2002","unstructured":"Leger F, Debord J, Le Meur Y, Rousseau A, Buchler M, Lachatre G, Paintaud G, Marquet P (2002) Maximum a posteriori Bayesian estimation of oral cyclosporine pharmacokinetics in stable renal transplant patients. Clin Pharmacokinet 41:71\u201380","journal-title":"Clin Pharmacokinet"},{"key":"0559_CR15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2165\/00003088-200140050-00004","volume":"40","author":"Debord","year":"2001","unstructured":"Debord J, Risco E, Harel M, Le Meur Y, Buchler M, Lachatre G, Le Guellec C, Marquet P (2001) Gamma distribution of absorption times: application to oral cyclosporine. Clin Pharmacokinet 40:375\u2013382","journal-title":"Clin Pharmacokinet"},{"key":"0559_CR16","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1016\/S0041-1345(98)00472-2","volume":"30","author":"Cooney","year":"1998","unstructured":"Cooney GF, Jeevanandam V, Choudhury S, Feutren G, Mueller EA, Eisen HJ (1998) Comparative bioavailability of Neoral and Sandimmune in cardiac transplant recipients over 1\u00a0year. Transplant Proc 30:1892\u20131894","journal-title":"Transplant Proc"},{"key":"0559_CR17","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2165\/00003088-199019040-00004","volume":"19","author":"Yee","year":"1990","unstructured":"Yee GC, McGuire TR (1990) Pharmacokinetic drug interactions with cyclosporin (Part II). Clin Pharmacokinet 19:319\u2013332","journal-title":"Clin Pharmacokinet"},{"key":"0559_CR18","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/BF01070904","volume":"9","author":"D'Argenio","year":"1981","unstructured":"D'Argenio DZ (1981) Optimal sampling times for pharmacokinetic experiments. J Pharmacokinet Biopharm 9:739\u2013756","journal-title":"J Pharmacokinet Biopharm"},{"key":"0559_CR19","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF01060893","volume":"9","author":"Sheiner","year":"1981","unstructured":"Sheiner LB, Beal SL (1981) Some suggestions for measuring predictive performance. J Pharmacokinet Biopharm 9:503\u2013512","journal-title":"J Pharmacokinet Biopharm"},{"key":"0559_CR20","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/00007691-199908000-00085","volume":"21","author":"David","year":"1999","unstructured":"David O, Johnston A, Cooney G (1999) Sparse sample measurements of cyclosporine AUC after Neoral in heart transplant patients. Ther Drug Monit 21:447","journal-title":"Ther Drug Monit"},{"key":"0559_CR21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s002280050718","volume":"56","author":"Wacke","year":"2000","unstructured":"Wacke R, Rohde B, Engel G, Kundt G, Hehl EM, Bast R, Seiter H, Drewelow B (2000) Comparison of several approaches of therapeutic drug monitoring of cyclosporin A based on individual pharmacokinetics. Eur J Clin Pharmacol 56:43\u201348","journal-title":"Eur J Clin Pharmacol"},{"key":"0559_CR22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00007890-199907150-00011","volume":"68","author":"Mahalati","year":"1999","unstructured":"Mahalati K, Belitsky P, Sketris I, West K, Panek R (1999) Neoral monitoring by simplified sparse sampling area under the concentration\u2013time curve: its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation. Transplantation 68:55\u201362","journal-title":"Transplantation"},{"key":"0559_CR23","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1097\/00007890-199812270-00009","volume":"66","author":"Cantarovich","year":"1998","unstructured":"Cantarovich M, Barkun JS, Tchervenkov JI, Besner JG, Asperlet L, Metrakos P (1998) Comparison of Neoral dose monitoring with cyclosporine trough levels versus 2-hr postdose levels in stable liver transplant patients. Transplantation 66:1621\u20131627","journal-title":"Transplantation"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-003-0559-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-003-0559-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-003-0559-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-003-0559-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T12:23:19Z","timestamp":1749730999000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-003-0559-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3,6]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["0559"],"URL":"https:\/\/doi.org\/10.1007\/s00228-003-0559-5","relation":{},"ISSN":["0031-6970"],"issn-type":[{"type":"print","value":"0031-6970"}],"subject":[],"published":{"date-parts":[[2003,3,6]]}}}